| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2003 | EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/12/2003 | EP0969877B1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 02/12/2003 | EP0947514B1 Novel phenanethridinium derivatives |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0941112B1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 02/12/2003 | EP0937078B1 Tricyclic carbapenem compounds |
| 02/12/2003 | EP0889690B1 Antibiotic cocktail and method of use |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0871456B1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
| 02/12/2003 | EP0868424B1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 02/12/2003 | EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof |
| 02/12/2003 | EP0862456A4 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/12/2003 | EP0828488B1 Isothiazolones |
| 02/12/2003 | EP0820292B1 Inhibition of c. difficile infections by indigestible oligosaccharides |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | EP0730459B1 The use of an ester of inositoltrisphosphate for the preparing of medicaments |
| 02/12/2003 | EP0711154B1 Stabilized pharmaceutical composition containing bupropion |
| 02/12/2003 | EP0669920B1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/12/2003 | CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 02/12/2003 | CN1396926A Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396918A Formulation for protection against oxidative stress containging benzofuranone derivatives |
| 02/12/2003 | CN1396917A Chromatographic separation method of paclitaxel and cephalomannin |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396911A Isolation of carotenoid crystals |
| 02/12/2003 | CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/12/2003 | CN1396906A Calcilytic compounds |
| 02/12/2003 | CN1396904A Novel compound, their preparation and use |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396834A Stabilised pharmaceutical compositions and process for their preparation comprising antibiobic and expectorant |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396831A Pharmaceutical preparation and method for treatment of diabetes |
| 02/12/2003 | CN1396830A Pharmaceutical parenteral composition containing biphosphonate |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1396828A Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/12/2003 | CN1396826A Use of pramipexole for treatment of addictive disorders |
| 02/12/2003 | CN1396825A Composition, kit for benefitting cardiovasaclaire and method |
| 02/12/2003 | CN1396824A Eye drops |
| 02/12/2003 | CN1396173A Gene sequence of genital regulation factor enriched in hypothalamus of Epinephelus and its usage |
| 02/12/2003 | CN1396172A Process for extracting compound cordycepin and its Chinese medicine |
| 02/12/2003 | CN1396170A Crystal form of Pifuadefuwei |
| 02/12/2003 | CN1396165A Zilpaterol hydrochcoride monohydrate |
| 02/12/2003 | CN1396164A Rusuan Jiatishaxing and its usage |
| 02/12/2003 | CN1396155A Garlicin extracted reversely by supercritical CO2 and process for preparing its injection |
| 02/12/2003 | CN1395948A Medicine 'Bixueling' for treating epistaxis |
| 02/12/2003 | CN1395943A Disinfecting liniment and its preparing process |
| 02/12/2003 | CN1395938A Veterinary oral liquid containing oligofructose |
| 02/12/2003 | CN1395937A Application of chrysopdyose in preparing medicine to treat inflammatory enteropathy and its preparing process |
| 02/12/2003 | CN1395936A Health-care food for protecting gastric mucosa and its preparing process |
| 02/12/2003 | CN1395935A Citicoline sodium injection for intravenous injection and its preparing process |
| 02/12/2003 | CN1395934A Locally applied composite medicine for treating pointed condyloma |
| 02/12/2003 | CN1395933A Medicine for treating cardiovascular and cerebrovascular diseases |
| 02/12/2003 | CN1395932A Application of estrin/progestogen/anti-progestogen, its composition and medicine box |
| 02/12/2003 | CN1395931A Oral-applied slow-releasing or release-controllable solid clozapine |
| 02/12/2003 | CN1395930A Slow-releasing maclobemide tablet |
| 02/12/2003 | CN1395929A Slow-releasing maclobemide capsule |
| 02/12/2003 | CN1395928A Slow-releasing acipimox tablet |
| 02/12/2003 | CN1395927A Slow-releasing acipimox capsule |
| 02/12/2003 | CN1395926A Application of p-bis (n-alasulfonyl) benzoic acid in veterinary medicine |
| 02/12/2003 | CN1395925A Slow-releasing Anixitan tablet |
| 02/12/2003 | CN1395924A Slow-releasing Anixidan capsule |
| 02/12/2003 | CN1395923A Application of xanthiphenylketamine or its salt in preparing medicines to treat cardiovascalar disease |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1395921A Application of torreyaester in resisting HIV |
| 02/12/2003 | CN1395920A Medicine for treating tinear manuum and tinear pedis |
| 02/12/2003 | CN1101425C Stable aqueous dispersions and stable water-dispersible dry xanthophyll powder, there production and use |
| 02/12/2003 | CN1101397C Preparation of beta-methyl carbepenem intermediate |
| 02/12/2003 | CN1101396C Isolation of claulanic acid from fermentation broth by ultrafiltration |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101391C Farnesyl transferase inhibiting 2-quinolone derivatives |
| 02/12/2003 | CN1101386C Trisubsted phenyl derivitives |
| 02/12/2003 | CN1101385C Substituted benzimidazole derivatives and its preparation method and medicine use |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/12/2003 | CN1101382C Derivatives of 10,11-dihydro-10-oxo-5H-dibenz/b.f/azepine-5-carboxamide |
| 02/12/2003 | CN1101380C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101214C Extenal use disinfectant anagesic and production method thereof |
| 02/12/2003 | CN1101206C Hematopoietic oral liquid and its preparing process |
| 02/12/2003 | CN1101205C Natural herbal medicine composition with function of sotpping itching, disinfection and antiphlogosis and its preparation method |
| 02/12/2003 | CN1101195C Process for preparing exterir-applied medicine for treating psoriasis |
| 02/12/2003 | CN1101192C Compositions for topical treatment of erectile impotence |
| 02/12/2003 | CN1101191C Carbamazepine medicament with retarded active substance release |
| 02/12/2003 | CN1101190C HIV protease inhibitor combination medicine |
| 02/12/2003 | CN1101189C Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as active ingredient |
| 02/12/2003 | CN1101188C use of green porphyrins in manufacture of medicament in treatment of atherosclerosis without purposeful irradiation of porphyrin derivatives |
| 02/12/2003 | CN1101187C Fluoxetine pharmaceutial formulations |
| 02/12/2003 | CN1101186C Broiler ascites preventive agent and method of preventing ascites |
| 02/12/2003 | CN1101183C Sustained release and implantation type mitomycin medicine and method for preparing same |
| 02/12/2003 | CN1101181C Haemorrhoidal compositions and method of use |
| 02/12/2003 | CN1101180C Cosmetics and/or composition for treating skin disease and use thereof |
| 02/11/2003 | US6518458 (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
| 02/11/2003 | US6518450 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity |